| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/16/1999 | CA2322824A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 09/16/1999 | CA2322771A1 Human membrane spanning proteins |
| 09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |
| 09/16/1999 | CA2322741A1 Thrombin preparation and products and fibrin sealant methods employing same |
| 09/16/1999 | CA2322732A1 Secreted proteins and polynucleotides encoding them |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322666A1 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding |
| 09/16/1999 | CA2322663A1 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2322508A1 Modified factor viii |
| 09/16/1999 | CA2322503A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0942002A1 Iron-casein complex and process for preparing the same |
| 09/15/1999 | EP0941736A1 Oral immunity enhancing agent containing peptidoglycans |
| 09/15/1999 | EP0941369A2 Dna for evaluating the progression potential of cervical lesions |
| 09/15/1999 | EP0941364A1 Process aimed at evidencing the state of a malignant cell and process for treatment |
| 09/15/1999 | EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941344A1 HUMANIZED ANTI-CD11a ANTIBODIES |
| 09/15/1999 | EP0941343A1 Pancreatic lipases and/or recombinant colipases and derived polypeptides produced by plants, methods for obtaining them and use thereof |
| 09/15/1999 | EP0941342A1 Human squalene epoxidase |
| 09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 09/15/1999 | EP0941339A1 Therapeutic gene |
| 09/15/1999 | EP0941336A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
| 09/15/1999 | EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences |
| 09/15/1999 | EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 09/15/1999 | EP0941333A1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 09/15/1999 | EP0941331A1 Processed polypeptides with il-16 activity, processes for their production and their use |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 09/15/1999 | EP0941328A1 Human breast tumor-specific proteins |
| 09/15/1999 | EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 09/15/1999 | EP0941326A1 Murine guanine nucleotide exchange factor (mngef) and human homologues thereof |
| 09/15/1999 | EP0941325A1 Human homolog of the latheo gene |
| 09/15/1999 | EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 09/15/1999 | EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
| 09/15/1999 | EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 09/15/1999 | EP0941319A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences |
| 09/15/1999 | EP0941317A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941315A1 Immune responses using compositions containing stress proteins |
| 09/15/1999 | EP0941313A1 Prostate-specific kallikrein |
| 09/15/1999 | EP0941311A2 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 09/15/1999 | EP0941309A1 Cellular adjuvant |
| 09/15/1999 | EP0941252A1 Anti-p53 single-chain antibody fragments and their uses |
| 09/15/1999 | EP0941251A1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| 09/15/1999 | EP0941249A1 Novel histamine h2 receptor |
| 09/15/1999 | EP0941248A1 Platelet secretory transport protein |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941246A2 Novel protein, its production and use |
| 09/15/1999 | EP0941245A1 Promoter for smooth muscle cell expression |
| 09/15/1999 | EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 09/15/1999 | EP0941242A2 Secreted proteins and polynucleotides encoding them |
| 09/15/1999 | EP0941240A1 New picornaviruses, vaccines and diagnostic kits |
| 09/15/1999 | EP0941239A1 Vertebrate homologues of unc-53 protein of c. elegans |
| 09/15/1999 | EP0941238A2 Mutant forms of fas ligand and uses thereof |
| 09/15/1999 | EP0941237A1 Cyclic hexapeptides having antibiotic activity |
| 09/15/1999 | EP0941236A1 Cyclohexapeptides having antimicrobial activity |
| 09/15/1999 | EP0941235A1 Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| 09/15/1999 | EP0941234A1 Preprotachykinin-c gene encoding substance z tachykinin precursor |
| 09/15/1999 | EP0941233A2 Antiviral peptide derivatives |
| 09/15/1999 | EP0941218A1 Antithrombotic organic nitrates |
| 09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
| 09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
| 09/15/1999 | EP0941121A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
| 09/15/1999 | EP0941120A1 Branched peptide linkers |
| 09/15/1999 | EP0941116A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 09/15/1999 | EP0941115A1 Use of growth hormone or a growth hormone secretagogue for promoting bone formation |
| 09/15/1999 | EP0941114A1 Use of glp-1 peptides |
| 09/15/1999 | EP0941113A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 09/15/1999 | EP0941112A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 09/15/1999 | EP0941111A1 Hepatocyte growth factor antagonists |
| 09/15/1999 | EP0941110A1 Uses of keratinocyte growth factor-2 |
| 09/15/1999 | EP0941109A1 Pretreatment with growth factors to protect against cns damage |
| 09/15/1999 | EP0941108A1 Wound healing and treatment of fibrosis |
| 09/15/1999 | EP0941107A1 Factors which interact with oncoproteins |
| 09/15/1999 | EP0941106A1 Agent for the metabolic treatment of multiple sclerosis |
| 09/15/1999 | EP0941105A1 Pretraumatic use of hemoglobin |
| 09/15/1999 | EP0941104A1 Peptide synthesis with sulfonyl protecting groups |
| 09/15/1999 | EP0941067A2 Stable glassy state powder formulations |
| 09/15/1999 | EP0941056A1 Sphingomyelinase compositions and use thereof |
| 09/15/1999 | EP0832098A4 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/15/1999 | EP0748383B1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
| 09/15/1999 | EP0679194B1 Method to predict active growth of bacteria adhered to a surface |
| 09/15/1999 | EP0652767B1 Treatment of human lactation failure |
| 09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
| 09/15/1999 | CN1228811A Modulators of BRCAI activity |
| 09/15/1999 | CN1228783A Thrombin inhibitor |
| 09/15/1999 | CN1228708A Peptide-containing drug compositions for oral administration |
| 09/15/1999 | CN1228707A Titanium slow-release composition |
| 09/15/1999 | CN1228339A Sponge material capable of promoting spinal cord tissue wound healing, its preparing method and use |
| 09/15/1999 | CN1228338A Wound covering material capable of promoting wound healing |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/14/1999 | US5952490 Oligonucleotides having a conserved G4 core sequence |
| 09/14/1999 | US5952488 A nucleic acid molecule containing an androgen response element linked to a reporter gene; diagnosis and therapy for prostatic diseases and cancer |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952482 Production of hemoglobin having a δ-like globin |
| 09/14/1999 | US5952481 DNA encoding ubiquitin conjugating enzymes |
| 09/14/1999 | US5952469 Murine UCP3 polypeptides |
| 09/14/1999 | US5952468 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |